Abstract:Abstract Background Clinical manifestation of the inflammatory bowel disease (IBD) shows considerable variation across the world. We hypothesized these differences may be influenced by geographical differences in gut microbiome. To test this, we investigated the correlation between gut microbiota and the disease phenotypes of IBD in a cohort form the Northern part of India. Methods Stool samples and clinical metadata were collected from 226 IBD patients (198 ulcerative colitis and 28 Crohn’s disease) and 66 controls from a population cohort from the Northern India. We used metagenomic shotgun sequencing to determine diversity, composition and function of the gut microbiota of the participants. Microbiome was then associated to IBD and its subtypes and clinical metadata (e.g. medication use, drug response, and disease activity). We replicated our results in 436 IBD patients and 903 population controls from the Netherlands analyzed using an identical workflow and used machine learning to assess how well do the Indian IBD signals generalize to Dutch IBD. Results We identified reduction in microbiome diversity and changes in beta diversity in Indian IBD patients (FDR < 0.05, replicated in Dutch population) and identified that 319 taxa and 71 biochemical pathways are altered in Indian patients (FDR < 0.05). Of note, 39% of these signals were replicated in the Dutch cohort (at FDR < 0.05 level). We identified strong dysbiosis shared across Indian and Dutch IBD patients, characterized by expansion of opportunistic pathogens (e.g. Genera Clostridium, Streptococcus and Lactobacilli) and oral bacteria (e.g. Streptococcus oralis and Bifidobacterium dentium) as well as reduction in butyrate producers such as Faecalibacterium prausnitzii, Roseburia hominis and Blautia massiliensis. In addition, we found novel pathobionts specific to the Indian cohort (including oral bacteria from Genus Scardovia and Oribacterium; Actinomyces dentalis and Klebsiella pneumoniae). Machine-learning models trained on the Indian cohort were highly predictive in the Indian test set (Sensitivity 0.84, Specificity 0.95) and generalized to Dutch cohort (Sensitivity 0.77, Specificity 0.69). In addition to IBD-associated dysbiosis, we identified links between medication use and gut microbiota independent of the disease activity: use of Tofacitinib (used by 26 UC patients) was linked to decrease in Lactobacilliales and increase in Clostridia, while Prednisolone and Azathioprine associated to reduction in Roseburia and increase in Streptococcus and Granulicatella. Conclusion The IBD patients from Northern India show gut dysbiosis similar to European patients, but also show enrichment in India-specific pathobionts. The microbiome-based diagnostic models generalize across these populations.

Depletion of core microbiome forms the shared background against diverging dysbiosis patterns in Crohn's disease and intestinal tuberculosis: insights from an integrated multi-cohort analysis

Differential prevalence of pathobionts and host gene polymorphisms in chronic inflammatory intestinal diseases: Crohn's disease and intestinal tuberculosis

Inter-kingdom relationships in Crohn's disease explored using a multi-omics approach

An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?

Alterations of Gut Microbiota in Patients with Intestinal Tuberculosis That Different from Crohn’s Disease

P1230 Integrated analysis of microbiome and metabolome reveals disease-specific profiles in inflammatory bowel disease and intestinal Behcet’s disease

Integrated Analysis of Microbiome and Metabolome Reveals Disease-Specific Profiles in Inflammatory Bowel Diseases and Intestinal Behçet's Disease

DOP26 Metagenomic and metabolomic profiles in IBD: understanding microbial and metabolic shifts from a large deeply phenotyped cohort

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection

Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases

Integrative Multi-Omics Deciphers the Spatial Characteristics of Host-Gut Microbiota Interactions in Crohn’s Disease

Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis

Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases

Gut microbiota signatures in inflammatory bowel disease

DOP30 Cross-ethnic microbiome analyses identify shared and specific signals for Northern Indian IBD patients

Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases

Gut microbiome structure and metabolic activity in inflammatory bowel disease

Two Distinct Metacommunities Characterize the Gut Microbiota in Crohn'S Disease Patients

Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders